Aztreonam avibactam pharmacokinetics describes how the two components of this combination behave in the body after administration, including their absorption, distribution, exposure, elimination and relationship to pharmacodynamic targets. Aztreonam is a beta-lactam antibacterial agent, while avibactam is a...
Introduction Aztreonam avibactam for Stenotrophomonas maltophilia is an emerging area of interest because this organism has intrinsic resistance mechanisms that limit the activity of many conventional β-lactam antibiotics. Stenotrophomonas maltophilia is a Gram-negative organism that can cause healthcare-associated...
Introduction Aztreonam avibactam for NDM-producing Enterobacterales has become an important area of interest in the management of antimicrobial-resistant Gram-negative infections. NDM, or New Delhi metallo-β-lactamase, is a metallo-β-lactamase (MBL) that can hydrolyze many β-lactam antibiotics, including carbapenems. However,...
The aztreonam avibactam mechanism of action is based on the complementary activity of two components: aztreonam, a monobactam antibiotic, and avibactam, a non-beta-lactam beta-lactamase inhibitor. Aztreonam targets bacterial cell-wall synthesis by binding primarily to penicillin-binding protein 3 (PBP3),...
Understanding the Meblanios mechanism of action requires looking at the two active components separately: Aztreonam and Avibactam. Meblanios contains Aztreonam 1500 mg and Avibactam 500 mg. Aztreonam is the antibacterial component, while Avibactam is a beta-lactamase inhibitor. The...
